NAFLD |
Non-alcoholic fatty liver disease |
NASH |
Non-alcoholic steatohepatitis |
TAG |
triglycerides |
HTS |
high-throughput screening |
HCS |
high-content screening |
HCA |
high-content analysis |
BSA |
bovine serum albumin |
OA |
oleic acid |
PA |
palmitic acid |
TG |
thapsigargin |
FA |
free fatty acid |
S/B |
signal-to-background ratio |
Z’ |
Z’-factor coefficient |
CDK2 |
cyclin D3-cyclin-dependent kinase 2 |
CDK4 |
cyclin D3-cyclin-dependent kinase 4 |
CEBPA |
CCAAT enhancer binding protein alpha |
CEBPB |
CCAAT enhancer binding protein beta |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
EP300 |
α-histone acetyltransferase E1A Binding Protein P300 |